138 related articles for article (PubMed ID: 36669426)
21. Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on Intergroup Study 0034.
Laramore GE; Scott CB; al-Sarraf M; Haselow RE; Ervin TJ; Wheeler R; Jacobs JR; Schuller DE; Gahbauer RA; Schwade JG
Int J Radiat Oncol Biol Phys; 1992; 23(4):705-13. PubMed ID: 1618662
[TBL] [Abstract][Full Text] [Related]
22. Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.
Noronha V; Joshi A; Patil VM; Agarwal J; Ghosh-Laskar S; Budrukkar A; Murthy V; Gupta T; D'Cruz AK; Banavali S; Pai PS; Chaturvedi P; Chaukar D; Pande N; Chandrasekharan A; Talreja V; Vallathol DH; Mathrudev V; Manjrekar A; Maske K; Bhelekar AS; Nawale K; Kannan S; Gota V; Bhattacharjee A; Kane S; Juvekar SL; Prabhash K
J Clin Oncol; 2018 Apr; 36(11):1064-1072. PubMed ID: 29220295
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
[TBL] [Abstract][Full Text] [Related]
24. Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck.
Suntharalingam M; Haas ML; Van Echo DA; Haddad R; Jacobs MC; Levy S; Gray WC; Ord RA; Conley BA
Cancer; 2001 Feb; 91(3):548-54. PubMed ID: 11169937
[TBL] [Abstract][Full Text] [Related]
25. Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas.
Lee DJ; Cosmatos D; Marcial VA; Fu KK; Rotman M; Cooper JS; Ortiz HG; Beitler JJ; Abrams RA; Curran WJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):567-76. PubMed ID: 7790241
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant radiotherapy mitigates impact of perineural invasion on oncologic outcomes in early-stage oral cavity squamous cell carcinoma. A multi-institutional analysis of 557 patients.
Holcomb AJ; Farrokhian N; Tolan C; Whiteford E; Villwock M; Kakarala K; Shnayder Y; Sykes K; Lominska C; Gan G; Buchakjian MR; Harding B; Dooley L; Shinn J; Burton Wood C; Rohde S; Khaja S; Abt NB; Varvares M; Bur AM
Oral Oncol; 2023 Jul; 142():106420. PubMed ID: 37182430
[TBL] [Abstract][Full Text] [Related]
27. Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.
Nguyen-Tan PF; Le QT; Quivey JM; Singer M; Terris DJ; Goffinet DR; Fu KK
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1172-80. PubMed ID: 11483326
[TBL] [Abstract][Full Text] [Related]
28. Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial.
Bossi P; Lo Vullo S; Guzzo M; Mariani L; Granata R; Orlandi E; Locati L; Scaramellini G; Fallai C; Licitra L
Ann Oncol; 2014 Feb; 25(2):462-6. PubMed ID: 24401930
[TBL] [Abstract][Full Text] [Related]
29. Extranodal extension in resected oral cavity squamous cell carcinoma: more to it than meets the eye.
Agarwal JP; Kane S; Ghosh-Laskar S; Pilar A; Manik V; Oza N; Wagle P; Gupta T; Budrukkar A; Murthy V; Swain M
Laryngoscope; 2019 May; 129(5):1130-1136. PubMed ID: 30421434
[TBL] [Abstract][Full Text] [Related]
30. Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial.
Licitra L; Grandi C; Guzzo M; Mariani L; Lo Vullo S; Valvo F; Quattrone P; Valagussa P; Bonadonna G; Molinari R; Cantù G
J Clin Oncol; 2003 Jan; 21(2):327-33. PubMed ID: 12525526
[TBL] [Abstract][Full Text] [Related]
31. Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial.
Ghi MG; Paccagnella A; Ferrari D; Foa P; Alterio D; Codecà C; Nolè F; Verri E; Orecchia R; Morelli F; Parisi S; Mastromauro C; Mione CA; Rossetto C; Polsinelli M; Koussis H; Loreggian L; Bonetti A; Campostrini F; Azzarello G; D'Ambrosio C; Bertoni F; Casanova C; Emiliani E; Guaraldi M; Bunkheila F; Bidoli P; Niespolo RM; Gava A; Massa E; Frattegiani A; Valduga F; Pieri G; Cipani T; Da Corte D; Chiappa F; Rulli E;
Ann Oncol; 2017 Sep; 28(9):2206-2212. PubMed ID: 28911070
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program.
Jacobs C; Makuch R
J Clin Oncol; 1990 May; 8(5):838-47. PubMed ID: 2185340
[TBL] [Abstract][Full Text] [Related]
33. Postoperative radiotherapy in squamous cell carcinoma of the oral cavity: the importance of the overall treatment time.
Langendijk JA; de Jong MA; Leemans CR; de Bree R; Smeele LE; Doornaert P; Slotman BJ
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):693-700. PubMed ID: 14529773
[TBL] [Abstract][Full Text] [Related]
34. Alternating chemoradiotherapy versus partly accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck: results from a phase III randomized trial.
Corvò R; Benasso M; Sanguineti G; Lionetto R; Bacigalupo A; Margarino G; Pallestrini E; Merlano M; Vitale V; Rosso R
Cancer; 2001 Dec; 92(11):2856-67. PubMed ID: 11753959
[TBL] [Abstract][Full Text] [Related]
35. Assessing Prognostic Value of Quantitative Neck Dissection Quality Measures in Patients With Clinically Node-Negative Oral Cavity Squamous Cell Carcinoma.
Farrokhian N; Holcomb AJ; Dimon E; Karadaghy O; Ward C; Whiteford E; Tolan C; Hanly EK; Buchakjian MR; Harding B; Dooley L; Shinn J; Wood CB; Rohde S; Khaja S; Parikh A; Bulbul MG; Penn J; Goodwin S; Bur AM
JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):947-955. PubMed ID: 36074415
[TBL] [Abstract][Full Text] [Related]
36. Patterns of Care in Adjuvant Therapy for Resected Oral Cavity Squamous Cell Cancer in Elderly Patients.
Pollom EL; Chin AL; Lee NY; Tsai CJ
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):758-766. PubMed ID: 28366574
[TBL] [Abstract][Full Text] [Related]
37. Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma.
Wise-Draper TM; Gulati S; Palackdharry S; Hinrichs BH; Worden FP; Old MO; Dunlap NE; Kaczmar JM; Patil Y; Riaz MK; Tang A; Mark J; Zender C; Gillenwater AM; Bell D; Kurtzweil N; Mathews M; Allen CL; Mierzwa ML; Casper K; Jandarov R; Medvedovic M; Lee JJ; Harun N; Takiar V; Gillison M
Clin Cancer Res; 2022 Apr; 28(7):1345-1352. PubMed ID: 35338369
[TBL] [Abstract][Full Text] [Related]
38. Concurrent cisplatin and dose escalation with intensity-modulated radiotherapy (IMRT) versus conventional radiotherapy for locally advanced head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial.
Tao Y; Auperin A; Blanchard P; Alfonsi M; Sun XS; Rives M; Pointreau Y; Castelli J; Graff P; Wong Hee Kam S; Thariat J; Veresezan O; Heymann S; Renard-Oldrini S; Lafond C; Cornely A; Casiraghi O; Boisselier P; Lapeyre M; Biau J; Bourhis J
Radiother Oncol; 2020 Sep; 150():18-25. PubMed ID: 32417348
[TBL] [Abstract][Full Text] [Related]
39. Hyperfractionated accelerated radiation therapy (HART) of 70.6 Gy with concurrent 5-FU/Mitomycin C is superior to HART of 77.6 Gy alone in locally advanced head and neck cancer: long-term results of the ARO 95-06 randomized phase III trial.
Budach V; Stromberger C; Poettgen C; Baumann M; Budach W; Grabenbauer G; Marnitz S; Olze H; Wernecke KD; Ghadjar P
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):916-24. PubMed ID: 25670541
[TBL] [Abstract][Full Text] [Related]
40. Concurrent mitomycin C, 5-fluorouracil, and radiotherapy in the treatment of locally advanced carcinoma of the cervix: a randomized trial.
Lorvidhaya V; Chitapanarux I; Sangruchi S; Lertsanguansinchai P; Kongthanarat Y; Tangkaratt S; Visetsiri E
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1226-32. PubMed ID: 12654431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
